S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

ANGLE (AGL) Share Forecast, Price & News

GBX 103.48
-0.03 (-0.02%)
(As of 05/16/2022 08:02 AM ET)
Today's Range
50-Day Range
52-Week Range
30,728 shs
Average Volume
655,735 shs
Market Capitalization
£243.32 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive AGL News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

ANGLE logo


ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application. It also offers specialist circulating tumor cell enrichment and analysis services to support translational research studies and pharmaceutical trials. The company was founded in 1994 and is based in Guildford, the United Kingdom.


ANGLE (LON:AGL) Rating Reiterated by Berenberg Bank
ANGLE garners industry interest following poster presentation
ANGLE technology used in metastatic breast cancer research
See More Headlines

Industry, Sector and Symbol

Medical Laboratories & Research
Year Founded

Sales & Book Value

Annual Sales
£1.01 million
Cash Flow
GBX 13.60 per share
Book Value
GBX 17.20 per share


Pretax Margin




Free Float
Market Cap
£243.32 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

1.53 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

ANGLE (LON:AGL) Frequently Asked Questions

Is ANGLE a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ANGLE stock.
View analyst ratings for ANGLE
or view top-rated stocks.

How were ANGLE's earnings last quarter?

ANGLE plc (LON:AGL) released its quarterly earnings data on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter.
View ANGLE's earnings history

What price target have analysts set for AGL?

1 brokerages have issued 1-year price objectives for ANGLE's stock. Their forecasts range from GBX 195 to GBX 195. On average, they expect ANGLE's share price to reach GBX 195 in the next twelve months. This suggests a possible upside of 88.5% from the stock's current price.
View analysts' price targets for ANGLE
or view top-rated stocks among Wall Street analysts.

Who are ANGLE's key executives?
ANGLE's management team includes the following people:
  • Mr. Andrew David William Newland, Founder, CEO & Exec. Director (Age 60, Pay $392k)
  • Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 57, Pay $251k)
  • Mr. Andrew John Holder, Head of Investor Relations
  • Mr. Paul Smith, Chief Commercial Officer
  • Dr. Madeline Repollet, Head of Clinical Laboratories
  • Ms. Anne-Sophie Pailhes-Jimenez, Head of R&D - ANGLE Europe Ltd.
  • Mr. Martin Cooke, Director of Manufacturing & Regulatory Affairs (Age 53)
  • Mr. Michael O'Brien, Bus. Devel. Director
What other stocks do shareholders of ANGLE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

How do I buy shares of ANGLE?

Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 103.48.

How much money does ANGLE make?

ANGLE has a market capitalization of £243.32 million and generates £1.01 million in revenue each year.

How many employees does ANGLE have?

ANGLE employs 102 workers across the globe.

What is ANGLE's official website?

The official website for ANGLE is www.angleplc.com.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.